Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$13,894
-$3,122 QoQ
Shares Held
577
-4.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,727
of 2,820 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aspect Partners, LLC holds $583,966 across 9 Drug Manufacturers - General names. PFE ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
570 | $144,762 | |
| 2 | LLY |
ELI LILLY & Co
|
101 | $121,142 | |
| 3 | AMGN |
Amgen Inc
|
333 | $120,585 | |
| 4 | MRK |
Merck & Co., Inc.
|
703 | $90,335 | |
| 5 | ABBV |
AbbVie Inc.
|
249 | $62,658 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
177 | $22,362 | |
| 7 | PFE |
Pfizer Inc
This page
|
577 | $13,894 | |
| 8 | NVO |
Novo Nordisk A S
|
166 | $7,958 |
All Filings in PFE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,894 | 577 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $17,016 | 606 | Shares | Other | 2026-04-02 | |
| 2025-12-31 | $20,592 | 827 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $21,071 | 827 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $43,777 | 1,806 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $19,689 | 777 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $20,613 | 777 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $21,154 | 731 | Shares | Other | 2024-10-15 | |
| 2024-06-30 | $20,452 | 731 | Shares | Other | 2024-07-15 | |
| 2024-03-31 | $18,925 | 682 | Shares | Other | 2024-05-17 | |
| 2023-12-31 | $17,474 | 607 | Shares | Other | 2024-02-16 | |
| No filing history on record for this holder in this stock. | ||||||